Global prevalence, treatment and outcome of tuberculosis and COVID-19 coinfection: a systematic review and meta-analysis (from November 2019 to March 2021)

INTRODUCTION: The COVID-19 outbreak poses a significant threat to the patients with tuberculosis (TB). TB and COVID-19 (TB–COVID) coinfection means the disease caused by both Mycobacterium tuberculosis and SARS-CoV-2 infection. Currently, the prevalence status, treatment and outcomes of the coinfect...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Quan, Guo, Shasha, Wei, Xiaolin, Dong, Quanfang, Xu, Ning, Li, Hui, Zhao, Jie, Sun, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Global Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213780/
https://www.ncbi.nlm.nih.gov/pubmed/35725250
http://dx.doi.org/10.1136/bmjopen-2021-059396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213780/
https://www.ncbi.nlm.nih.gov/pubmed/35725250
http://dx.doi.org/10.1136/bmjopen-2021-059396

Ejemplares similares